Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Panbela Therapeutics Inc (EM) PBLA

Healthcare Biotechnology
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of disruptive therapeutics for the treatment of patients with urgent unmet medical needs. The company’s lead product candidates are Ivospemin (SBP-101), a proprietary polyamine analogue, which has completed Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal... see more

Current News (EXPM:PBLA)

Panbela Provides Business Update and Reports Q3 2024 Financial Results

GlobeNewswire November 14, 2024

Panbela to Host Third Quarter 2024 Earnings Conference Call on November 14, 2024

GlobeNewswire October 31, 2024

First Patient Enrolled in Phase I Program in STK11 Mutant Non-Small Cell Lung Cancer at Moffitt Cancer Center

GlobeNewswire September 24, 2024

Panbela Provides Business Update and Reports Q2 2024 Financial Results

GlobeNewswire August 13, 2024

Panbela to Host Second Quarter 2024 Earnings Conference Call on Aug 13, 2024

GlobeNewswire July 30, 2024

Panbela Therapeutics Announces Third Independent Safety Review of Phase 3 ASPIRE Clinical Trial DSMB Recommended Continuation with No Trial Modification

GlobeNewswire June 24, 2024

Panbela Announces Oral Presentation at Digestive Disease Week (DDW):

GlobeNewswire June 10, 2024

Panbela Provides Business Update and Reports Q1 2024 Financial Results

GlobeNewswire May 15, 2024

Panbela Announces Issuance of New Patent in the US and Canada; Patent is for Claims of a Fixed Dose Combination of Eflornithine and Sulindac

GlobeNewswire May 6, 2024
View More News ››

Opinion & Analysis (EXPM:PBLA)

No current opinion is available.
View More Opinion ››

Bullboard Posts (EXPM:PBLA)

Panbela Therapeutics, Inc. (PBLA): Navigating the Challenges

http://beyondspx.com/2024/07/31/panbela-therapeutics-inc-pbla-navigating-the-challenges-of-advancing-innovative-therapeutics/
MikeTester - August 2, 2024

RE:PBLA ..... JUst remember what this game is all about!!!!

All I can say to all those that didn't listen is ....... I fore-warned you! Here is this a.m's NR...... Panbela Announces...
Iseneschal - January 29, 2024

PBLA .... I wish u all the best during AH

I don't trade After Hours Just remember that there will be a P.O announcement sooner than later and the share price will tank...
Iseneschal - January 26, 2024

PBLA .... I am keeping all my profit

Not giving The Maggot squat ; ) Don't care where it goes to
Iseneschal - January 26, 2024

PBLA ....you just might be surprised how fast this can rip

15 mis left before the close
Iseneschal - January 26, 2024

PBLA....don't get greedy

Cheers !
Iseneschal - January 26, 2024
View more Bullboard ››

Lode Gold Resources Inc.

Lode Gold Resources Inc.

Lode Gold Resources Inc., together with its subsidiaries, engages in the acquisition and exploration of mineral resource ...
View More »

Podcasts